Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.

Bioorg Med Chem Lett

Pfizer Inc, Global Reseach & Development, Groton Laboratories, Eastern Point Rd., 06340, Groton, CT, USA.

Published: July 2003

Phosphinic acid-based inhibitors of MMP-13 have been investigated with the aim of identifying potent inhibitors with high selectivity versus MMP-1. Independent variation of the substituents on a P(1)' phenethyl group and a P(2) benzyl group improved potencies in both cases around 3-fold over the unsubstituted parent. Combining improved P(1)' and P(2) groups into a single molecule gave an inhibitor with a 4.5 nM IC(50) against MMP-13 and which is 270-fold selective over MMP-1.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00413-xDOI Listing

Publication Analysis

Top Keywords

phosphinic acid-based
8
acid-based mmp-13
4
mmp-13 inhibitors
4
inhibitors spare
4
spare mmp-1
4
mmp-1 mmp-3
4
mmp-3 phosphinic
4
acid-based inhibitors
4
inhibitors mmp-13
4
mmp-13 investigated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!